Long-Term Locoregional Outcomes in a Contemporary Cohort of Young Women With Breast Cancer
Authors:
- 23 July 2025
- journal article
- Published by American Medical Association (AMA) in JAMA Surgery
Abstract
Importance: Women diagnosed with breast cancer at a young age are felt to have a higher risk for locoregional recurrence (LRR) regardless of type of local therapy.Objective: To assess the long-term incidence of isolated LRR by molecular subtype in a modern multicenter cohort of young women.Design, Setting, and Participants: This cohort study, a multicenter prospective study named the Young Women’s Breast Cancer Study, enrolled 1302 women diagnosed with breast cancer at 40 years or younger from 2006 to 2016. Treatment information and incident LRR (ipsilateral breast/chest or lymph node recurrence) were self-reported on study surveys and confirmed with medical record review; molecular subtype was determined by record review. Analysis was reported from February 2023 to May 2025.Main Outcomes and Measures: Cumulative incidence of isolated LRR was calculated using the Kaplan-Meier method; hazard ratios were estimated by Cox proportional hazards regression.Results: The cohort included 1135 women with stage I through III breast cancer who had a median follow-up of 10.1 years (range, 0.4-16.3 years). The age at diagnosis was younger than 30 years for 145 patients (12.8%), 31 to 35 years for 318 patients (28.0%), and 36 to 40 years for 672 patients (59.2%). There were 59 isolated local recurrences (5.2%) and 4 isolated regional recurrences (0.4%). Among patients with local therapy and subtype data available (n = 1128), 366 (32%) had luminal A–like tumors; 240 (21%), luminal B–like tumors; 231 (20%) luminal ERBB2 positive (+)–like (formerly HER2 positive); 90 (8%) ERBB2+-like; and 201 (18%) triple negative. A total of 346 women (30%) had breast-conserving therapy (BCT) (98% of whom had radiation), 296 (26%) unilateral mastectomy, and 487 (43%) bilateral mastectomy. Of women who had mastectomy, 425 (54%) had radiation. The cumulative incidence of LRR at 10.1 years by subtype was as follows: luminal A, 4.4% (range, 1.0%-6.9%); luminal B, 4.7% (range 1.8%-7.7%); luminal ERBB2+, 6.1% (range, 3.1%-8.3%); ERBB2+, 2.2% (range, 0%-6.3%); and triple negative, 6.5% (range, 4.2%-10.1%). The cumulative incidence of LRR by locoregional treatment type at 10.1 years was 6.7% after BCT (range, 4.3%-10.1%), 6.5% after mastectomy without radiation (range, 0%-7.7%), and 2.4% after mastectomy with radiation (range, 1%-4.2%). Although mastectomy with radiation was associated with the lowest risk of LRR on multivariable analysis, when examined within molecular subtype, there were no differences seen.Conclusions and Relevance: In this contemporary cohort of women diagnosed with breast cancer at age 40 years or younger, risk of isolated LRR was relatively low (5.6%) at a median follow-up of 10.1 years, and significant differences were not seen by tumor subtype. Concerns for long-term risk of LRR should not influence surgical decision-making with young women, irrespective of molecular subtype.Keywords
This publication has 33 references indexed in Scilit:
- Risk of first recurrence after treatment in a population-based cohort of young women with breast cancerBreast Cancer Research and Treatment, 2024
- Patterns in Cancer Incidence Among People Younger Than 50 Years in the US, 2010 to 2019JAMA Network Open, 2023
- Locoregional Recurrence Patterns in Patients With Different Molecular Subtypes of Breast CancerJAMA Surgery, 2023
- Genomic characterisation of hormone receptor-positive breast cancer arising in very young womenAnnals of Oncology, 2023
- Association of Local Therapy With Quality-of-Life Outcomes in Young Women With Breast CancerJAMA Surgery, 2021
- Local–regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial)Breast Cancer Research and Treatment, 2019
- Breast-cancer subtype, age, and lymph node status as predictors of local recurrence following breast-conserving therapyBreast Cancer Research and Treatment, 2016
- Temporal Trends in Postmastectomy Radiation Therapy and Breast Reconstruction Associated With Changes in National Comprehensive Cancer Network GuidelinesJAMA Oncology, 2016
- The importance of systemic therapy in minimizing local recurrence after breast‐conserving surgery: The NSABP experienceJournal of Surgical Oncology, 2014
- Are breast conservation and mastectomy equally effective in the treatment of young women with early breast cancer? Long-term results of a population-based cohort of 1,451 patients aged ≤40 yearsBreast Cancer Research and Treatment, 2010